Full-Time

Director – Product & Portfolio Strategy

Posted on 5/8/2024

Beam Therapeutics

Beam Therapeutics

201-500 employees

Pioneering CRISPR base editing genetic medicines

Biotechnology

Senior

Cambridge, MA, USA

Required Skills
Marketing
Requirements
  • BS/BA in a relevant academic field; MBA, MD, PhD, or other graduate degree strongly preferred
  • Minimum 10 years business experience within the pharma/biotech/biopharma space
  • Demonstrated marketing experience and proven performance required; in-line marketing experience preferred
  • Proven ability to collaborate cross-functionally and to build relationships with internal and external stakeholders
  • Ability to think strategically and solve problems creatively
  • Skilled at navigating ambiguity and developing solutions in the absence of complete information
  • Experience with product launch highly preferred
  • Experience with cell and gene therapies highly preferred
  • Experience with U.S. marketing highly preferred
Responsibilities
  • Responsible for generating insights into the sickle cell and genetic medicines treatment landscape, stakeholder needs and treatment decision making
  • Leads development of the BEAM-101 brand plan, including competitive differentiation, customer segmentation and targeting, positioning, and messaging
  • Contributes to the development and execution of the integrated launch plan for BEAM-101
  • Collaborates with other functions (e.g. medical affairs, market access, patient supply, patient advocacy) in shaping HCP engagement strategy, customer experience, disease state education etc.
  • Leads development of short- and long-term professional marketing strategies and tactics
  • Budget management
  • Forecast and long-range financial planning
  • Competitive monitoring

Beam Therapeutics is a cutting-edge biopharmaceutical company specializing in CRISPR base editing technology. This innovative approach enables precise, permanent modifications to single bases in DNA and RNA, paving the way for advanced genetic medicines tailored to cure serious diseases. The firm's commitment to precision and potential to offer life-long relief for patients make it an outstanding workplace for professionals passionate about leading transformative healthcare solutions.

Company Stage

IPO

Total Funding

$689M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-14%

2 year growth

12%